Gene · 8030
Papers1,913
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,913
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The impact of procalcitonin in assessing outcomes in pediatrics severe trauma cases: A three-year experience from a tertiary hospital. | Biomedicine (Taipei) | 2023 | 37168730 | PubTator, text mining | PubMed |
| Response to Pralsetinib in Multi-Drug-Resistant Breast Cancer With CCDC6-RET Mutation. | Oncologist | 2023 | 37141396 | PubTator, text mining | PubMed |
| Molecular and clinical features of papillary thyroid cancer in adult patients with a non-classical phenotype. | Front Endocrinol (Lausanne) | 2023 | 37124750 | PubTator, text mining | PubMed |
| Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer. | Pharmaceutics | 2023 | 37111737 | PubTator, text mining | PubMed |
| Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics. | Pharmaceuticals (Basel) | 2023 | 37111371 | PubTator, text mining | PubMed |
| Advances in Drug Discovery Targeting Lysosomal Membrane Proteins. | Pharmaceuticals (Basel) | 2023 | 37111358 | PubTator, text mining | PubMed |
| Highly sensitive droplet digital PCR for detection of RET fusion in papillary thyroid cancer. | BMC Cancer | 2023 | 37081420 | PubTator, text mining | PubMed |
| Targeting RET Solvent-Front Mutants with Alkynyl Nicotinamide-Based Inhibitors. | Mol Cancer Ther | 2023 | 37070927 | PubTator, text mining | PubMed |
| Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications. | Clin Cancer Res | 2023 | 37061987 | PubTator, text mining | PubMed |
| MicroRNA-142-3p promotes renal cell carcinoma progression by targeting RhoBTB3 to regulate HIF-1 signaling and GGT/GSH pathways. | Sci Rep | 2023 | 37045834 | PubTator, text mining | PubMed |
| A single-nucleus transcriptome-wide association study implicates novel genes in depression pathogenesis. | medRxiv | 2023 | 37034737 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Phase separation in cancer at a glance. | J Transl Med | 2023 | 37005672 | PubTator, text mining | PubMed |
| Plasma ctDNA increases tissue NGS-based detection of therapeutically targetable mutations in lung cancers. | BMC Cancer | 2023 | 37004022 | PubTator, text mining | PubMed |
| Response to selpercatinib in a patient with RET fusion-positive pulmonary large-cell neuroendocrine carcinoma: A case report. | Front Oncol | 2023 | 36998440 | PubTator, text mining | PubMed |
| Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung Cancers. | Clin Cancer Res | 2023 | 36996322 | PubTator, text mining | PubMed |
| Structural basis for severe pain caused by mutations in the S4-S5 linkers of voltage-gated sodium channel NaV1.7. | Proc Natl Acad Sci U S A | 2023 | 36996107 | PubTator, text mining | PubMed |
| Molecular Genetics of Diffuse Sclerosing Papillary Thyroid Cancer. | J Clin Endocrinol Metab | 2023 | 36995892 | PubTator, text mining | PubMed |
| The heterogeneous transition state of resistance to RET kinase inhibitors converges on ERK1/2-driven Aurora A/B kinases. | Drug Resist Updat | 2023 | 36990046 | PubTator, text mining | PubMed |
| Autophagy-Related MicroRNA: Tumor miR-125b and Thyroid Cancers. | Genes (Basel) | 2023 | 36980957 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8030/papers?page=14